Insmed Incorporated
INSM
$149.33
-$0.67-0.45%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 66.73% | 30.34% | 21.15% | 20.77% | 19.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 66.73% | 30.34% | 21.15% | 20.77% | 19.17% |
| Cost of Revenue | 43.38% | 34.39% | 31.40% | 29.43% | 30.76% |
| Gross Profit | 73.94% | 29.15% | 18.19% | 18.34% | 16.00% |
| SG&A Expenses | 52.06% | 54.66% | 48.42% | 44.14% | 33.85% |
| Depreciation & Amortization | 18.78% | 5.44% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.20% | 37.29% | 36.33% | 24.48% | 16.64% |
| Operating Income | -26.47% | -40.68% | -44.08% | -26.20% | -15.51% |
| Income Before Tax | -39.74% | -36.97% | -28.78% | -35.61% | -21.83% |
| Income Tax Expenses | 35.58% | 37.86% | 49.38% | 51.45% | 45.09% |
| Earnings from Continuing Operations | -39.73% | -36.97% | -28.86% | -35.66% | -21.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.73% | -36.97% | -28.86% | -35.66% | -21.91% |
| EBIT | -26.47% | -40.68% | -44.08% | -26.20% | -15.51% |
| EBITDA | -26.07% | -40.82% | -44.49% | -26.48% | -15.64% |
| EPS Basic | -14.62% | -11.26% | -5.65% | -13.60% | -4.45% |
| Normalized Basic EPS | -3.43% | -12.24% | -14.02% | -2.45% | 3.09% |
| EPS Diluted | -14.66% | -11.30% | -5.66% | -13.59% | -4.49% |
| Normalized Diluted EPS | -3.43% | -12.24% | -14.02% | -2.45% | 3.09% |
| Average Basic Shares Outstanding | 21.29% | 22.40% | 22.35% | 19.97% | 16.79% |
| Average Diluted Shares Outstanding | 21.29% | 22.40% | 22.35% | 19.97% | 16.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |